CPT2 and glioblastoma: In agreement, GBM database analysis (http://www.cgga.org.cn/index.jsp) of 504 HGG containing 220 recurrent and 284 primary GBM (not matched) also revealed the elevated expression of CPT1A, CPT2, ACAD9, and CD47 in the recurrent tumors (Fig. 1e).